참고문헌
- Birkedal-Hansen H.(a) The role of cytokine and inflammatory mediators in tissue destruction. J Periodontol Res. 1993; 28:500-10. https://doi.org/10.1111/j.1600-0765.1993.tb02113.x
- Birkedal-Hansen H.(b) The role of matrix metalloproteinses in human periodontal diseases. J Periodontol. 1993;64:474-84.
- Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol. 2003;85:267-73. https://doi.org/10.1016/S0960-0760(03)00214-0
- Brandenburg K, Andrä J, Müller M, Koch MH, Garidel P. Physicochemical properties of bacterial glycopolymers in relation to bioactivity. Carbohydr Res. 2003;14:2477-89.
- Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;21: 1318-22.
- Cho N, Momose Y. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. Curr Top Med Chem. 2008;8:1483-507. https://doi.org/10.2174/156802608786413474
- Dongari-Bagtzoglou AI, Ebersole JL. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodont Res. 1996;31:90-8. https://doi.org/10.1111/j.1600-0765.1996.tb00469.x
- Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol. 1999;15:6403-12.
- Genco RJ. Host response in periodontal disease, current concept, mechanism of connective tissue matrix destruction in periodontitis. J Periodontol. 1992;63:338-55. https://doi.org/10.1902/jop.1992.63.4s.338
- Ingman T, Tervahartiala T, Ding Y, Tscherche H, Haerian A, Kinane DF, Konttinen YT, Sorsa T. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol. 1996; 23:1127-32. https://doi.org/10.1111/j.1600-051X.1996.tb01814.x
- Jiang C, Ting AT, Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:79-82. https://doi.org/10.1038/34178
- Lin TH, Yang RS, Tang CH, Lin CP, Fu WM. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone. 2007; 41:562-74. https://doi.org/10.1016/j.bone.2007.06.017
- McDaniel ML, Kwon G, Hill JR, Marshall CA, Corbett JA. Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med. 1996;211:24-32. https://doi.org/10.3181/00379727-211-43950D
- Mendez M, LaPointe MC. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. Hypertension. 2003;42: 844-50. https://doi.org/10.1161/01.HYP.0000085332.69777.D1
- Min JK, Kim YM, Kim SW, Kwon MC, Kong YY, Hwang IK, Won MH, Rho J, Kwon YG. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J Immunol. 2005;1:531-40.
- Naito Y, Yoshikawa T. Role of matrix metalloproteinases in inflammatory bowel disease. Mol Aspects Med. 2005;26: 379-90. https://doi.org/10.1016/j.mam.2005.07.009
- Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res. 1991;26: 230-42. https://doi.org/10.1111/j.1600-0765.1991.tb01649.x
- Rausch-Fan X, Matejka M. From plaque formation to periodontal disease, is there a role for nitric oxide? Eur J Clin Invest. 2001;31:833-5. https://doi.org/10.1046/j.1365-2362.2001.00903.x
- Ribeiro JM, Hazzard JM, Nussenzveig RH, Champagne DE, Walker FA. Reversible binding of nitric oxide by a salivary heme protein from a bloodsucking insect. Science. 1993;23: 539-41.
- Robinson-Rechavi M, Carpentier AS, Duffraisse M, Laudet V. How many nuclear-hormone receptors are there in the human genome? Trends Genet 2001;17:554-556. https://doi.org/10.1016/S0168-9525(01)02417-9
- Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996;1302:93-109. https://doi.org/10.1016/0005-2760(96)00066-5
- Salvemini DK, Seibert JL, Masferrer TP, Misko MG, Currie NP. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. Clin Invest. 1994; 93:1940-47. https://doi.org/10.1172/JCI117185
- Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol. 2005;32: 108-29. https://doi.org/10.1111/j.1600-051X.2005.00785.x
- Sung B, Park S, Yu BP, Chung HY. Modulation of PPAR in aging, inflammation, and calorie restriction. J Gerontol A Biol Sci Med Sci. 2004;59:997-1006. https://doi.org/10.1093/gerona/59.10.B997
- Villegas I, Martín AR, Toma W, de la Lastra CA. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur J Pharmacol. 2004;505:195-203. https://doi.org/10.1016/j.ejphar.2004.10.020
- Yu MK, Lee JC, Kim JH, Lee YH, Jeon JG, Jhee EC, Yi HK. Anti-inflammatory effect of peroxisome proliferator activated receptor gamma on human dental pulp cells. J Endod. 2009; 35:524-528. https://doi.org/10.1016/j.joen.2008.12.012
- Zetterquist W, Pedroletti C, Lundberg JO, Alving K. Salivary contribution to exhaled nitric oxide. Eur Respir J. 1999;13: 327-33. https://doi.org/10.1034/j.1399-3003.1999.13b18.x
- 서조영, 최재용, 유현모, 박준봉, 조준승. 치주인대세포와 치은섬유아세포의 성상에 관한 비교. 대한구강생물학회지. 1991;15:14-28.